Dieter Edbauer, M.D.

Curriculum Vitae

Dieter Edbauer studied medicine in Munich (1994-2000). In his doctoral work with Prof. M. Hallek at the Gene Center of the Ludwig-Maximilians-Universität (LMU), he worked on DNA vaccines against lymphomas (1998-2001). As physician in training (AiP), later as postdoc and then as research assistant, he transferred to the Adolf-Butenandt-Institut, LMU, where he studied the biochemical mechanisms of AD with Prof. C. Haass (2001-2004). As a highlight of this work a key enzyme of AD, the so called gamma-secretase, could be defined for the first time on a molecular basis. A stay abroad followed at the Massachusetts Institute of Technology (MIT) in the laboratory of Prof. M. Sheng (2004-2009). There he focused on signal transduction and cell biology in neurons in association with AD and the fragile X syndrome. In November 2009 Dr. Edbauer returned to Munich as the first Helmholtz junior research group leader at the newly founded DZNE. The aim of his research is to identify new therapeutic targets for AD by the analysis of the molecular mechanisms of synaptic dysfunction.